Katrina Bykova, PhD

Group Leader, Discovery Biology & Pharmacology at Xencor

Katrina Bykova, PhD, is a Associate Director in the Discovery Biology & Pharmacology department at Xencor, Inc. Her work at Xencor is focused on development of bispecific antibodies that are designed to modulate patient immune system to enhance the anti-tumor response. Prior to joining Xencor Katrina led target discovery efforts and therapeutic programs in the immune-oncology and autoimmunity fields at BMS and Amgen where she worked on T cell modulation and pathways targeting a myeloid component of the tumor microenvironment. Katrina holds a PhD in Pharmacology and Toxicology from University of California.